Matches in SemOpenAlex for { <https://semopenalex.org/work/W4379055324> ?p ?o ?g. }
- W4379055324 abstract "Introduction: Cerium oxide nanoparticles (CONPs) have been investigated for their therapeutic potential in Parkinson's disease (PD) due to their potent and regenerative antioxidant activity. In the present study, CONPs were used to ameliorate the oxidative stress caused by free radicals in haloperidol-induced PD in rats following intranasal administration. Method: The antioxidant potential of the CONPs was evaluated in vitro using ferric reducing antioxidant power (FRAP) assay. The penetration and local toxicity of the CONPs was evaluated ex-vivo using goat nasal mucosa. The acute local toxicity of intranasal CONPs was also studied in rat. Gamma scintigraphy was used to assess the targeted brain delivery of CONPs. Acute toxicity studies were performed in rats to demonstrate safety of intranasal CONPs. Further, open field test, pole test, biochemical estimations and brain histopathology was performed to evaluate efficacy of intranasal CONPs in haloperidol-induced PD rat model. Results: The FRAP assay revealed highest antioxidant activity of prepared CONPs at a concentration of 25 μg/mL. Confocal microscopy showed deep and homogenous distribution of CONPs in the goat nasal mucus layers. No signs of irritation or injury were seen in goat nasal membrane when treated with optimized CONPs. Scintigraphy studies in rats showed targeted brain delivery of intranasal CONPs and acute toxicity study demonstrated safety. The results of open field and pole test showed highly significant (p < 0.001) improvement in locomotor activity of rats treated with intranasal CONPs compared to untreated rats. Further, brain histopathology of treatment group rats showed reduced neurodegeneration with presence of more live cells. The amount of thiobarbituric acid reactive substances (TBARS) was reduced significantly, whereas the levels of catalase (CAT), superoxide dismutase (SOD), and GSH were increased significantly, while amounts of interleukin-6 (IL-6) and tumour necrosis factor-alpha (TNF-α) showed significant reduction after intranasal administration of CONPs. Also, the intranasal CONPs, significantly high (p < 0.001) dopamine concentration (13.93 ± 0.85 ng/mg protein) as compared to haloperidol-induced control rats (5.76 ± 0.70 ng/mg protein). Conclusion: The overall results concluded that the intranasal CONPs could be safe and effective therapeutics for the management of PD." @default.
- W4379055324 created "2023-06-02" @default.
- W4379055324 creator A5004946990 @default.
- W4379055324 creator A5020139866 @default.
- W4379055324 creator A5029876320 @default.
- W4379055324 creator A5050363056 @default.
- W4379055324 creator A5054621412 @default.
- W4379055324 creator A5059668646 @default.
- W4379055324 creator A5092069216 @default.
- W4379055324 date "2023-05-30" @default.
- W4379055324 modified "2023-09-27" @default.
- W4379055324 title "Intranasal cerium oxide nanoparticles improves locomotor activity and reduces oxidative stress and neuroinflammation in haloperidol-induced parkinsonism in rats" @default.
- W4379055324 cites W1123553450 @default.
- W4379055324 cites W1488734028 @default.
- W4379055324 cites W1837404641 @default.
- W4379055324 cites W1967033368 @default.
- W4379055324 cites W1990053570 @default.
- W4379055324 cites W1991728953 @default.
- W4379055324 cites W1993250284 @default.
- W4379055324 cites W2003021017 @default.
- W4379055324 cites W2011676749 @default.
- W4379055324 cites W2015058806 @default.
- W4379055324 cites W2039880215 @default.
- W4379055324 cites W2051370773 @default.
- W4379055324 cites W2083346475 @default.
- W4379055324 cites W2139131794 @default.
- W4379055324 cites W2142219833 @default.
- W4379055324 cites W2148512945 @default.
- W4379055324 cites W2154023615 @default.
- W4379055324 cites W2159575294 @default.
- W4379055324 cites W2162752807 @default.
- W4379055324 cites W2163875686 @default.
- W4379055324 cites W2165248451 @default.
- W4379055324 cites W2165292984 @default.
- W4379055324 cites W2165712226 @default.
- W4379055324 cites W2168784140 @default.
- W4379055324 cites W2172191264 @default.
- W4379055324 cites W2178406001 @default.
- W4379055324 cites W2258473744 @default.
- W4379055324 cites W2341666738 @default.
- W4379055324 cites W2395300225 @default.
- W4379055324 cites W2435053065 @default.
- W4379055324 cites W2557511039 @default.
- W4379055324 cites W2586960721 @default.
- W4379055324 cites W2589563852 @default.
- W4379055324 cites W2616807757 @default.
- W4379055324 cites W2740695644 @default.
- W4379055324 cites W2746724024 @default.
- W4379055324 cites W2764062762 @default.
- W4379055324 cites W2775863612 @default.
- W4379055324 cites W2780108202 @default.
- W4379055324 cites W2802587265 @default.
- W4379055324 cites W2883318157 @default.
- W4379055324 cites W2901519529 @default.
- W4379055324 cites W2993520592 @default.
- W4379055324 cites W3003486628 @default.
- W4379055324 cites W3004259340 @default.
- W4379055324 cites W3005212741 @default.
- W4379055324 cites W3020978143 @default.
- W4379055324 cites W3033190169 @default.
- W4379055324 cites W3036695163 @default.
- W4379055324 cites W3042059273 @default.
- W4379055324 cites W3044916089 @default.
- W4379055324 cites W3049634014 @default.
- W4379055324 cites W3111965812 @default.
- W4379055324 cites W3114915646 @default.
- W4379055324 cites W3122042396 @default.
- W4379055324 cites W3135672591 @default.
- W4379055324 cites W3137907604 @default.
- W4379055324 cites W3141258533 @default.
- W4379055324 cites W3152873732 @default.
- W4379055324 cites W3199938511 @default.
- W4379055324 cites W410623913 @default.
- W4379055324 cites W4206481149 @default.
- W4379055324 cites W4211123396 @default.
- W4379055324 cites W4220720141 @default.
- W4379055324 cites W4220870518 @default.
- W4379055324 cites W4286797643 @default.
- W4379055324 cites W4319228158 @default.
- W4379055324 cites W4322758181 @default.
- W4379055324 doi "https://doi.org/10.3389/fphar.2023.1188470" @default.
- W4379055324 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37324485" @default.
- W4379055324 hasPublicationYear "2023" @default.
- W4379055324 type Work @default.
- W4379055324 citedByCount "2" @default.
- W4379055324 countsByYear W43790553242023 @default.
- W4379055324 crossrefType "journal-article" @default.
- W4379055324 hasAuthorship W4379055324A5004946990 @default.
- W4379055324 hasAuthorship W4379055324A5020139866 @default.
- W4379055324 hasAuthorship W4379055324A5029876320 @default.
- W4379055324 hasAuthorship W4379055324A5050363056 @default.
- W4379055324 hasAuthorship W4379055324A5054621412 @default.
- W4379055324 hasAuthorship W4379055324A5059668646 @default.
- W4379055324 hasAuthorship W4379055324A5092069216 @default.
- W4379055324 hasBestOaLocation W43790553241 @default.
- W4379055324 hasConcept C116263406 @default.
- W4379055324 hasConcept C126322002 @default.
- W4379055324 hasConcept C185592680 @default.
- W4379055324 hasConcept C2776151105 @default.
- W4379055324 hasConcept C2778004101 @default.